Drug Profile
NBP 606
Alternative Names: 13-valent pneumococcal vaccine conjugate - SK Bioscience; 13vPnC - SK Bioscience; NBP-606Latest Information Update: 27 Sep 2021
Price :
$50
*
At a glance
- Originator SK Chemicals
- Developer SK Bioscience
- Class Conjugate vaccines; Pneumococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pneumococcal infections
Most Recent Events
- 27 Sep 2021 Discontinued - Phase-III for Pneumococcal infections (In infants, Prevention) in South Korea (IM)
- 27 Sep 2021 Discontinued - Phase-III for Pneumococcal infections (In the elderly, Prevention, Treatment-naive) in South Korea (IM)
- 02 Jul 2018 SK Chemicals divested the vaccine business portfolio to a newly formed subsidiary SK Bioscience